Inovio Pharmaceuticals INO reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Inovio Pharmaceuticals missed estimated earnings by 56.25%, reporting an EPS of $-0.5 versus an estimate of $-0.32.
Revenue was up $4.74 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04 which was followed by a 0.99% increase in the share price the next day.
Here's a look at Inovio Pharmaceuticals's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.33 | -0.25 | -0.18 | -0.22 |
| EPS Actual | -0.29 | -0.39 | -0.27 | -0.14 |
| Revenue Estimate | 970.00K | 1.21M | 850.00K | 1.11M |
| Revenue Actual | 291.70K | 272.82K | 371.12K | 5.58M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.